The hunt for the secrets of uveal melanoma

Clinical and Experimental Ophthalmology

Volumn 36, Issue 3, 2008, Pages 277-280

  Shields, Carol L ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b WILLS EYE HOSPITAL   (United States)

Author keywords

Eye; Genetics; Melanoma; Monosomy 3; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; IMMUNOLOGIC AGENT; PHOSPHOTRANSFERASE INHIBITOR; VASCULOTROPIN ANTIBODY;

CANCER REGRESSION; CHROMOSOME 3; CYTOGENETICS; ENVIRONMENTAL FACTOR; EYE COLOR; GENE MUTATION; HISTOPATHOLOGY; HUMAN; METASTASIS; MONOSOMY; OPHTHALMOSCOPY; REVIEW; RISK FACTOR; SKIN COLOR; SUBRETINAL FLUID; SUN EXPOSURE; SYMPTOM; UVEA MELANOMA;

CHROMOSOMES, HUMAN, PAIR 3; EARLY DIAGNOSIS; EYE COLOR; HUMANS; MELANOMA; MONOSOMY; OPHTHALMOSCOPY; PREDICTIVE VALUE OF TESTS; SKIN PIGMENTATION; SUNLIGHT; UVEAL NEOPLASMS;

EID: 42449102183     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2008.01717.x     Document Type: Review

References (41)

1. Weis E, Shah CP, Lajous M et al. The association between host susceptibility factors and uveal melaoma. A meta-analysis. Arch Ophthalmol 2006; 124: 54-60.
2. Shah CP, Weis E, Lajous M et al. Intermittent and chronic ultraviolet light exposure and uveal melanoma. A meta-analysis. Ophthalmol 2005; 112: 1599-607.
3. Holman CD, Armstrong BK. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984; 72: 257-66.
4. Barnhill RL, Mihm MC Jr, Fitzpatrick TB, Sober AJ. Neoplasms: Malignant melanoma. In: Fitzpatrick RB, Elsen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in General Medicine, 4th edn. New York: McGraw-Hill, 1993; pp. 1078-116.
5. Elwood JM, Jopson J. Melanoma and sun exposure: An overview of published studies. Int J Cancer 1997; 73: 198-203.
6. Butler P, Char DH, Zarbin M, Kroll S. Natural history of indeterminate pigmented choroidal tumors. Ophthalomology 1994; 101: 710-16.
7. Shields CL, Shields JA, Kiratli H et al. Risk factors for growth and metastasis of small choroidal melanocytic lesions. Ophthalmology 1995; 102: 1351-6.
8. Shields CL, Cater JC, Shields JA et al. Combination of clinical factors predictive of growth of small choroidal melanocytic tumors. Arch Ophthalmol 2000; 118: 360-4.
9. Collaborative Ocular Melanoma Study Group. Fact ors predictive of growth and treatment of small choroidal melanoma: COMS report no. 5. Arch Oophthalmol 1997; 115: 1537-44.
10. Eskelin S, Pyrhonen S, Summanen P et al. Tumor doubling times in metastatic malignant melanoma of the uvea. Tumor progression before and after treatment. Ophthalmology 2000; 107: 1443-9.
11. Eskelin S, Kivela T. Uveal melanoma: Implications of tumor doubling time. Ophthalmology 2001; 108: 830-1.
12. Shields JA, Shields CL. Choroidal nevus. In
13. Shields JA, Shields CL. Atlas of Intraocular Tumors. Philadelphia, PA: Lippincott Williams & Wilkins, 2007; 60-7.
14. Shields CL, Furuta M, Mashayekhi A et al. Clinical spectrum of choroidal nevi based on age at presentation in 3422 consecutive eyes. Ophthalmology 2008; 115: 546-52.
15. American Academy of Dermatology. Melanoma/Skin Cancer. You Can Recognize the Signs. Washington: The Academy, 1989.
16. Saida T. Lessons learned from studies of the development of early melanoma. Int J Clin Oncol 2005; 10: 371-4.
17. Diener-West M, Hawkins BS, Markowitz JA etal. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 1992; 110: 245-50.
18. Collaborative Ocular Melanoma Study Group. Trends in size and treatment of recently diagnosed choroidal melanoma, 1987-1997: Findings from patients examined at collaborative ocular melanoma study (COMS) centers: COMS report no. 20. Arch Ophthalmol 2003; 121: 1156-62.
19. Sisley K, Rennie IG, Cottam DW etal. Cytogenetic findings in six posterior uveal melanomas: Involvement of chromosomes 3, 6, and 8. Genes Chromosomes Cancer 1990; 2: 205-9.
20. Horsthemke B, Prescher G, Bornfeld N et al. Loss of chromosome 3 alleles and multiplication of chromosome 8 alleles in uveal melanoma. Genes Chromosomes Cancer 1992; 4: 217-21.
21. Prescher G, Bornfeld N, Hirche H et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996; 347: 1222-5.
22. Sisley K, Rennie IG, Parsons MA et al. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer 1997; 19: 22-8.
23. Sisley K, Parsons MA, Garnham J et al. Association of specific chromosome alteration with tumour phenotype in posterior uveal melanoma. Br J Cancer 2000; 82: 330-8.
24. Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004; 64: 7205-9.
25. Shields CL, Ganguly A, Materin M et al. Chromosome 3 analysis of uveal melanoma using fine needle aspiration biopsy at the time of plaque radiotherapy in 140 cases. The Deborah Iverson MD Lectureship. Arch Ophthalmol 2007; 125: 1017-24.
26. Patel KA, Edmondson ND, Talbot F et al. Prediction of prognosis in patients with uveal melanoma using FISH. Br J Ophthalmol 2001; 85: 1440-4.
27. Tschentscher F, Husing J, Holter T et al. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res 2003; 63: 2578-84.
28. Harbour JW. Molecular prognostic testing in uveal melanoma: Has it finally come of age? Arch Ophthalmol 2007; 125: 1122-3.
29. Shields JA, Shields CL, Materin M et al. Role of cytogenetics in management of uveal melanoma. Arch Ophthalmol 2008; 126: 416-9.
30. Midena E, Bonaldi L, Parrozzani R et al. in vivo detection of monosomy 3 in eyes with medium-sized uveal melanoma using transscleral fine needle aspiration biopsy. Eur J Ophthalmol 2006; 16: 422-5.
31. Young T, Rao NP, Glasgow BJ et al. Fluorescent in situ hybridization of monosomy 3 via 30-gauge fine-needles aspiration biopsy of choroidal melanoma in vivo. Ophthalmology 2007; 114: 142-6.
32. Shields CL, Materin MA, Teixiera L et al. Small choroidal melanoma with chromosome 3 monosomy on fine needle aspiration biopsy. Ophthalmology 2007; 114: 1919-24.
33. Scholes AG, Damato BE, Nunn J et al. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci 2003; 44: 1008-11.
34. Damato B, Duke C, Coupland SE et al. Cytogenetics of uveal melanoma. A 7-year clinical experience. Ophthalmology 2007; 114: 1925-31.
35. Augsburger JJ, Gamel JW, Shields JA et al. Post-irradiation regression of choroidal melanomas as a risk factor for death from metastatic disease. Ophthalmology 1987; 94: 1173-7.
36. Glynn RJ, Seddon JM, Gragoudas ES et al. Evaluation of tumor regression and other prognostic factors for early and late metastasis after proton irradiation of uveal melanoma. Ophthalmology 1989; 96: 1566-73.
37. Kaiserman I, Anteby I, Chowers I et al. Post-brachytherapy initial tumour regression rate correlates with metastatic spread in posterior uveal melanoma. Br J Ophthalmol 2004; 88: 892-5.
38. Shields JA, Shields CL. Prognostic factors for uveal melanoma. In: Gospodarowicz M, O'sullivan B, Sobin LH eds. Prognostic Factors in Cancer, 3rd edn. Hoboken, NJ: Wiley-Liss, Inc., 2006; 269-72.
39. Feldman ED, Pingpank JF, Alexander HR Jr. Regional treatment options for patients with ocular melanoma metastatic to the liver. Ann Surg Oncol 2004; 11: 290-7.
40. Sato T. Locoregional immunobiotherapy for liver metastases. Semin Oncol 2002; 29: 160-7.
41. Kasper B, D'Hondt V, Vereecken P, Awada A. Novel treatment strategies for malignant melanoma: A new beginning? Crit Rev Oncol Hematol 2007; 62: 16-22.